Get all your news in one place.

100’s of premium titles.
One app.

Get all your news in one place.

100’s of premium titles. One news app.

The Latest Breaking News from Vir Biotechnology

12 Health Care Stocks Moving In Friday's Intraday Session

5 Value Stocks To Watch In The Healthcare Sector

5 Value Stocks To Watch In The Healthcare Sector

What Defines a Value Stock?

Where Vir Biotechnology Stands With Analysts

Where Vir Biotechnology Stands With Analysts

Within the last quarter, Vir Biotechnology (NASDAQ:VIR) has observed the following analyst ratings:

From analysis to the latest developments in health,
read the most diverse news in one place.

inkl

Earnings Outlook For Vir Biotechnology

Vir Biotechnology (NASDAQ:VIR) is set to give its latest quarterly earnings report on Thursday, 2022-05-05. Here's what investors need to know before the announcement. Analysts estimate that Vir Biotechnology will report an earnings per share (EPS) of $3.78.

5 Value Stocks In The Healthcare Sector

What are Value Stocks?

Why Did FDA Pull Authorization For GSK-Vir's COVID-19 Therapy? Read Here

The U.S. health regulator said GlaxoSmithKline Plc (NYSE:GSK) and Vir Biotechnology Inc's (NASDAQ:VIR) antibody therapy was no longer authorized as a COVID-19 treatment. The decision was made as the CDC now estimates that the proportion of Covid-19 cases caused by BA.2 is above 50% nationwide. "Sotrovimab is no longer authorized to treat COVID-19 in any…

12 Health Care Stocks Moving In Wednesday's Intraday Session

inkl

Read news from The Economist, FT, and more,
with one subscription

35 Stocks Moving In Wednesday's Mid-Day Session

35 Stocks Moving In Wednesday's Mid-Day Session

Gainers Direct Digital Holdings, Inc. (NASDAQ: DRCT) shares jumped 82.6% to $4.71 after the company reported a year over year increase in Q4 sales results and issued Q1 sales guidance above analyst estimates.

24 Stocks Moving in Wednesday's Pre-Market Session

24 Stocks Moving in Wednesday's Pre-Market Session

Recap: Vir Biotechnology Q4 Earnings

Recap: Vir Biotechnology Q4 Earnings

Vir Biotechnology (NASDAQ:VIR) reported its Q4 earnings results on Thursday, February 24, 2022 at 04:00 PM. Here's what investors need to know about the announcement.

Organisations

Securities and Exchange Commission

GlaxoSmithKline Plc

Tenet Healthcare

Emergent BioSolutions

Revelation Biosciences

TransMedics Group

Vir Biotechnology

From analysis to the latest developments in health,
read the most diverse news in one place.

inkl

Topics

inkl

Read news from The Economist, FT, and more,
with one subscription

Places

314,233 stories

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.

Download on the AppStore

Get it on Google Play